SARS-CoV-2 RNA, strain hCoV-19/Netherlands/Gelderland_20949/2021, N501T (S), nextstrain clade 20D, lineage C.2
nucleic-acid

SARS-CoV-2 RNA, strain hCoV-19/Netherlands/Gelderland_20949/2021, N501T (S), nextstrain clade 20D, lineage C.2

EVAg
Produced by
: RIVM
Shipping From
: Bilthoven - NL

Product Description

Ref-SKU:
014N-04148
RNA extracted from infected cell culture supernatant containing SARS-CoV-2 strain hCoV-19/Netherlands/Gelderland_20949/2021, N501T (S), nextstrain clade 20D, lineage C.2.
Product Risk Group: 
RG1

Information on the related virus

ICTV Taxonomy: 
Riboviria / Orthornavirae / Pisuviricota / Pisoniviricetes / Nidovirales / Cornidovirineae / Coronaviridae / Orthocoronavirinae / Betacoronavirus / Sarbecovirus / Severe acute respiratory syndrome-related coronavirus
Virus name: 
SARS-CoV-2
Strain: 
hCoV-19/Netherlands/Gelderland_20949/2021, N501T (S), nextstrain clade 20D, lineage C.2


Unit definition: 
1 vial containing 250 µl

In stock

550,00 €
 (Cost per access for Academics)
Free access available

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Cloned Product: No
Can it be used to produce GMO: 
No
Sequencing: 
Fully sequenced
Sequence checked: 
Yes
Mutations: 
No mutation compared to the reference sequence
Nucleic Acid preparation technique: 
Roche, MagNA Pure, elution in 50 µl TE buffer, subsequently dilution in nuclease-free water
Titer: 
E gene: 1.25*10^7 cps/250 µl ; RdRP gene: 1.22*10^7 cps/250 µl (updated 9-6-21, 19:15)
Storage conditions: 
Nuclease-Free Water -80C
Shipping conditions: 
Dry ice
IATA Classification: 
NON DANGEROUS GOODS
Virus host type: 
Human virus
Previous Name or Taxonomy: 
2019-nCoV
nCoV-2019

Information about the origin of the product

Biological material origin: 
Natural origin
Collection date: 
Tuesday, 22 December, 2020
Country of collection: 
Netherlands (the)